Skip to content
Sıfırıncı Dakika
Latest

Science Corporation raises $400m to bring its sight-restoring chip to the US

Startups1 min read

In brief

Science Corporation, the brain-computer interface company founded by former Neuralink president Max Hodak, has raised a $400m Series D. According to a source familiar with the deal, the round values the company at $3.5bn. The company aims to bring its sight-restoring chip to the US market.

  • $400m Series D round
  • $3.5bn valuation
  • Chip aimed at restoring sight
  • Plans to enter the US market
  • Backers include Khosla Ventures, Tenet Healthcare and Y Combinator

The round and its backers

Science Corporation, the brain-computer interface company founded by former Neuralink president Max Hodak, has closed a $400m Series D round. A source familiar with the deal told TechCrunch that the round values the company at $3.5bn.

According to a blog post from the company, backers include Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare and Y Combinator.

What it does

Science Corporation works in the brain-computer interface (BCI) space. These technologies aim to read and interpret brain signals through electrodes placed in the nervous system.

The company's focus is a chip designed to restore lost vision. According to the report, it plans to bring that product to the US.

Why it matters

BCI has drawn growing attention from both the medical and investment sides in recent years. Science's round stands out as one of the larger funding moves in the sector.

However, the source text does not detail the chip's clinical status, approval process or a timeline for the US move.

Why it matters

As investment in brain-computer interfaces accelerates, this funding round is a key milestone for readers tracking the commercial and clinical path of sight-restoring chips.

Sources

Related stories